Advertisement

Ceftazidime Injection

[12 August 2015]

Products Affected - Description

Ceftazidime intravenous injection, BBraun
1 gram/50 mL, premixed bag, 24 count (NDC 00264-3143-11)
 
Ceftazidime intravenous powder for solution for injection, Sagent
1 gm vials, 25 count (NDC 25021-0127-20)
2 gm vials, 10 count (NDC 25021-0128-50)

Ceftazidime intravenous powder for solution for injection, Sandoz
1 gm vials, 25 count (NDC 00781-3177-96)
2 gm, vials, 10 count (NDC 00781-3178-95)
 
Ceftazidime intravenous powder for solution for injection, WG Critical Care
2 gram, vial, 10 count (NDC 44567-0236-10)
 
Tazicef intravenous powder for solution for injection, Hospira
1 gm vials, 25 count (NDC 00409-5082-16)
2 gm vials, 10 count (NDC 00409-5084-11)
6 gram, vial, 6 count (NDC 00409-5086-11)
 
Fortaz intravenous powder for solution for injection, Covis
6 gm vials, 6 count (NDC 24987-0382-37)

Reason for the Shortage

  • Covis had Fortaz premixed bags on shortage due to increased demand.
  • Hospira has Tazicef on shortage due to increased demand.
  • Sagent has ceftazidime injection on shortage due to manufacturing delays.

Available Products

Ceftazidime intravenous injection, BBraun
2 gram/50 mL, premixed bag, 24 count (NDC 00264-3145-11)
 
Ceftazidime intravenous powder for solution for injection, Sagent
6 gram, vial, 6 count (NDC 25021-0129-99)
 
Ceftazidime intravenous powder for solution for injection, Sandoz
6 gram, vial, 6 count (NDC 00781-3179-86)
 
Ceftazidime intravenous powder for solution for injection, WG Critical Care
1 gram, vial, 25 count (NDC 44567-0235-25)
6 gram, vial, 6 count (NDC 44567-0237-06)
 
Tazicef intravenous powder for solution for injection, Hospira
1 gram, ADD-Vantage vial, 25 count (NDC 00409-5092-16)
2 gram, ADD-Vantage vial, 10 count (NDC 00409-5093-11)
 
Fortaz intravenous injection, Covis
1 gram/50 mL, premixed bag, 24 count (NDC 24987-0412-00)
2 gram/50 mL, premixed bag, 24 count (NDC 24987-0413-00)
 
Fortaz intravenous powder for solution for injection, Covis
1 gram, vial, 10 count (NDC 24987-0378-10)
1 gram, TwistVials 25 count (NDC 24987-0434-00)
2 gram, vial, 10 count (NDC 24987-0379-34)
2 gram, TwistVials 10 count (NDC 24987-0435-00)
500 mg, vial, 10 count (NDC 24987-0377-10)

Estimated Resupply Dates

  • BBraun has ceftazidime 1 gram/50 mL premix available on allocation.
  • Covis has Fortaz 6 gram vials on back order and the company cannot estimate a released date.
  • Hospira has Tazicef 1 gram and 2 gram vials on back order and the company estimates a release date of September 2015. Tazicef 6 gram vials are on back order until mid-August 2015.
  • Sagent has ceftazidime 1 gram vials on back order and the company estimates a release date of August 2015. Ceftazidime 2 gram vials are on allocation.
  • Sandoz has ceftazidime 1 gram and 2 gram vials on back order and the company estimates a release date of late-September 2015.
  • WG Critical Care has ceftazidime 2 gram vials on back order and the company cannot estimate a release date. Check with wholesalers for availability.

Related Shortages

Updated

August 12, July 21 and 2, June 5 and 11, May 5 and 21, April 8 and 27, March 3, February 9 and 20, January 7 and 23, 2015; December 1, 17, and 22, November 4 and 21, October 3, September 5, August 1 and 15, July 3 and 17, June 3 and 24, April 2 and 24, March 3, February 24, January 6 and 24, 2014; December 4 and 20, November 13, October 10 and 14, August 1, 29, and 30, July 11 and 18, June 13, May 20, April 17 and 24, March 8, February 13, January 14 and 28, 2013; December 10 and 24, November 16 and 30, October 22, September 6, 17, and 27, August 9, July 5 and 25, June 1 and 12, May 16, April 24, March 30, February 8, January 10, 2012; December 21, November 29, 2011, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement